» Articles » PMID: 37335041

An Automatic Interpretable Deep Learning Pipeline for Accurate Parkinson's Disease Diagnosis Using Quantitative Susceptibility Mapping and T1-weighted Images

Abstract

Parkinson's disease (PD) diagnosis based on magnetic resonance imaging (MRI) is still challenging clinically. Quantitative susceptibility maps (QSM) can potentially provide underlying pathophysiological information by detecting the iron distribution in deep gray matter (DGM) nuclei. We hypothesized that deep learning (DL) could be used to automatically segment all DGM nuclei and use relevant features for a better differentiation between PD and healthy controls (HC). In this study, we proposed a DL-based pipeline for automatic PD diagnosis based on QSM and T1-weighted (T1W) images. This consists of (1) a convolutional neural network model integrated with multiple attention mechanisms which simultaneously segments caudate nucleus, globus pallidus, putamen, red nucleus, and substantia nigra from QSM and T1W images, and (2) an SE-ResNeXt50 model with an anatomical attention mechanism, which uses QSM data and the segmented nuclei to distinguish PD from HC. The mean dice values for segmentation of the five DGM nuclei are all >0.83 in the internal testing cohort, suggesting that the model could segment brain nuclei accurately. The proposed PD diagnosis model achieved area under the the receiver operating characteristic curve (AUCs) of 0.901 and 0.845 on independent internal and external testing cohorts, respectively. Gradient-weighted class activation mapping (Grad-CAM) heatmaps were used to identify contributing nuclei for PD diagnosis on patient level. In conclusion, the proposed approach can potentially be used as an automatic, explainable pipeline for PD diagnosis in a clinical setting.

Citing Articles

Explainable Machine Learning Models for Brain Diseases: Insights from a Systematic Review.

Rodriguez Mallma M, Zuloaga-Rotta L, Borja-Rosales R, Rodriguez Mallma J, Vilca-Aguilar M, Salas-Ojeda M Neurol Int. 2024; 16(6):1285-1307.

PMID: 39585057 PMC: 11587041. DOI: 10.3390/neurolint16060098.


Classification of Parkinson's disease by deep learning on midbrain MRI.

Welton T, Hartono S, Lee W, Teh P, Hou W, Chen R Front Aging Neurosci. 2024; 16:1425095.

PMID: 39228827 PMC: 11369979. DOI: 10.3389/fnagi.2024.1425095.


Quantitative susceptibility mapping based basal ganglia segmentation via AGSeg: leveraging active gradient guiding mechanism in deep learning.

Xi J, Huang Y, Bao L Quant Imaging Med Surg. 2024; 14(7):4417-4435.

PMID: 39022266 PMC: 11250355. DOI: 10.21037/qims-23-1858.


Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.

Zarkali A, Thomas G, Zetterberg H, Weil R Nat Commun. 2024; 15(1):5661.

PMID: 38969680 PMC: 11226684. DOI: 10.1038/s41467-024-49949-9.


A more objective PD diagnostic model: integrating texture feature markers of cerebellar gray matter and white matter through machine learning.

Chen Y, Qi Y, Li T, Lin A, Ni Y, Pu R Front Aging Neurosci. 2024; 16:1393841.

PMID: 38912523 PMC: 11190310. DOI: 10.3389/fnagi.2024.1393841.


References
1.
Lim I, Faria A, Li X, Hsu J, Airan R, Mori S . Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures. Neuroimage. 2013; 82:449-69. PMC: 3966481. DOI: 10.1016/j.neuroimage.2013.05.127. View

2.
Berg D, Youdim M . Role of iron in neurodegenerative disorders. Top Magn Reson Imaging. 2006; 17(1):5-17. DOI: 10.1097/01.rmr.0000245461.90406.ad. View

3.
Abdul-Rahman H, Gdeisat M, Burton D, Lalor M, Lilley F, Moore C . Fast and robust three-dimensional best path phase unwrapping algorithm. Appl Opt. 2007; 46(26):6623-35. DOI: 10.1364/ao.46.006623. View

4.
Smith S . Fast robust automated brain extraction. Hum Brain Mapp. 2002; 17(3):143-55. PMC: 6871816. DOI: 10.1002/hbm.10062. View

5.
Haacke E, Liu S, Buch S, Zheng W, Wu D, Ye Y . Quantitative susceptibility mapping: current status and future directions. Magn Reson Imaging. 2014; 33(1):1-25. DOI: 10.1016/j.mri.2014.09.004. View